Low magnesium levels decrease the activity of insulin receptor tyrosine kinase, which reduces the effectiveness of insulin signaling.
Strongly supported
Multiple high-quality studies back this claim.
Not medical advice. For informational purposes only. Always consult a healthcare professional.
Low magnesium levels decrease the activity of insulin receptor tyrosine kinase, which reduces the effectiveness of insulin signaling.
See the technical phrasing
Magnesium deficiency impairs insulin signaling by reducing insulin receptor tyrosine kinase activity.
When magnesium is low, the insulin receptor cannot activate properly because magnesium is needed for its enzyme to work. This stops the receptor from sending signals inside the cell, so glucose cannot enter muscle and fat cells, causing blood sugar to rise.
What the research says
Supports
1 study
Study: Magnesium Deficiency and Its Impact on the Development of Insulin Resistance in Obese Individuals
This study provides evidence supporting the claim.
Contradicts
0 studies
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies